as on
| Source : BSE
as on August 22, 2025 at 4:01 PM IST
Day's Low
Day's High
1.72%
Downside
4.50%
Upside
52 Week's Low
52 Week's High
53.30%
Downside
22.09%
Upside
Market Stats | |
Previous Close | ₹19.11 |
Open | ₹19.49 |
Volume | 61.36K |
Upper Circuit | ₹20.06 |
Lower Circuit | ₹18.16 |
Day's Low | ₹18.33 |
Day's High | ₹19.49 |
52 Week Low | ₹8.71 |
52 Week High | ₹22.77 |
Returns % | |
1 Month Return | + 1.7 % |
3 Month Return | + 64.32 % |
1 Year Return | + 119.4 % |
3 Year Return | + 305.73 % |
5 Year Return | + 537 % |
Check Kabra Drugs Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹45.31 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
0Return on capital employed (ROCE)
0Beta (LTM)
0.26
P/B Ratio
-2.15
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-9.09
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Get the annual and quarterly financial summary of Kabra Drugs Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Kabra Drugs Ltd.
Kabra Drugs Ltd’s net profit jumped 9.09% since last year same period to ₹0.50Cr in the Q1 2025-2026. On a quarterly growth basis, Kabra Drugs Ltd has generated -228.21% fall in its net profits since last 3-months.
Read More about Earnings ResultsView the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Kabra Drugs Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 0% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 100% | 0.00 | |
Others | 0% | 0.00 |
Compare market cap, revenue, PE, and other key metrics of Kabra Drugs Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 45.31 | 107.4% | 0.00 | -1 | NA | |
NA | 144.70 | 17.83% | 0.84 | 7 | 339 | |
NA | 509.12 | 22.09% | 0.00 | NA | NA | |
NA | 732.08 | 31.15% | 0.51 | 421 | 1,280 | |
NA | 6.03 | -7.89% | 0.00 | -6 | NA |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, Kabra Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
In the last 3 months, Kabra Drugs stock has moved up by 64.3%
Best in 1 Year
In the last 1 year, Kabra Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 100.00% of holdings in Jun 2025 quarter
Organisation | Kabra Drugs Ltd |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Kabra Drugs Ltd share price today stands at ₹18.65, Open: ₹19.49, Previous Close: ₹19.11, High: ₹19.49, Low: ₹18.33, 52 Week High: ₹22.77, 52 Week Low: ₹8.71 as on .
To buy Kabra Drugs Ltd shares, you need to follow these steps:
Today's traded volume of Kabra Drugs Ltd is 61.36K. Which means that 61.36K shares of Kabra Drugs Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Kabra Drugs Ltd is ₹45.31 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Kabra Drugs Ltd’s 52 week high is ₹22.77 and 52 week low is ₹8.71. The current share price of Kabra Drugs Ltd is ₹18.65, which is -18.09% down from its 52 week high and 114.12% up from its 52 week low.